Lates News

The revenue of stone medicine group was 26.01 billion yuan for the whole year, with an estimated 27.82 billion yuan. The net profit of stone medicine group for the whole year was 3.88 billion yuan, with an estimated 4.87 billion yuan. The end-of-period dividend per share of Stone Pharmaceutical Group is 0.15 Hong Kong dollars.